Long-term trends in rheumatology care
Background Since 1993, data on the care and quality of life of patients with inflammatory rheumatic diseases have been collected in the German National Database (NDB) of the regional collaborative rheumatology centers. Objective In this review long-term trends on treatment, disease activity and gain...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Albrecht, K. [verfasserIn] Callhoff, J. [verfasserIn] Zink, A. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2019 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
Enthalten in: Zeitschrift für Rheumatologie - Steinkopff-Verlag, 1998, 78(2019), Suppl 2 vom: 12. Aug., Seite 65-72 |
|---|---|
| Übergeordnetes Werk: |
volume:78 ; year:2019 ; number:Suppl 2 ; day:12 ; month:08 ; pages:65-72 |
| Links: |
|---|
| DOI / URN: |
10.1007/s00393-019-0680-1 |
|---|
| Katalog-ID: |
SPR00484257X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR00484257X | ||
| 003 | DE-627 | ||
| 005 | 20230519174951.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201001s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00393-019-0680-1 |2 doi | |
| 035 | |a (DE-627)SPR00484257X | ||
| 035 | |a (SPR)s00393-019-0680-1-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Albrecht, K. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Long-term trends in rheumatology care |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Background Since 1993, data on the care and quality of life of patients with inflammatory rheumatic diseases have been collected in the German National Database (NDB) of the regional collaborative rheumatology centers. Objective In this review long-term trends on treatment, disease activity and gainful employment of the most common inflammatory rheumatic diseases are presented and the most important analyses from 25 years of the NDB are summarized. Methods Between 15 and 17 rheumatological institutions take part in the NDB and once a year collect data from a total of more than 10,000 patients. The rheumatologists document the disease status and care, the patients report on their state of health and the effects of the disease. Results The biologics era at the beginning of the twenty-first century has led to changes in the therapeutic spectrum of most inflammatory rheumatic diseases, especially in rheumatoid arthritis and ankylosing spondylitis. Some basic therapies formerly used are hardly used anymore and glucocorticoids are used less frequently. Methotrexate has remained the standard therapy for rheumatoid arthritis over the years. Nowadays, nearly 30% of patients with rheumatoid arthritis receive treatment with biologics. Disease activity, functional and social restrictions have decreased across all diseases. Conclusion The improved health status of many patients with rheumatic diseases confirms the high level of care provided by the rheumatism centers involved in the NDB. The increasing specification of measuring instruments and the standardization of documentation systems are major challenges that the NDB will have to face in the coming years if it is to remain in the digital age. | ||
| 650 | 4 | |a Inflammatory rheumatic diseases |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Treatment |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Disease burden |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Level of care |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Quality of life |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Callhoff, J. |e verfasserin |4 aut | |
| 700 | 1 | |a Zink, A. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Zeitschrift für Rheumatologie |d Steinkopff-Verlag, 1998 |g 78(2019), Suppl 2 vom: 12. Aug., Seite 65-72 |w (DE-627)SPR004818482 |7 nnns |
| 773 | 1 | 8 | |g volume:78 |g year:2019 |g number:Suppl 2 |g day:12 |g month:08 |g pages:65-72 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s00393-019-0680-1 |z kostenfrei |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 78 |j 2019 |e Suppl 2 |b 12 |c 08 |h 65-72 | ||
| author_variant |
k a ka j c jc a z az |
|---|---|
| matchkey_str |
albrechtkcallhoffjzinka:2019----:ogemrnsnhuao |
| hierarchy_sort_str |
2019 |
| publishDate |
2019 |
| allfields |
10.1007/s00393-019-0680-1 doi (DE-627)SPR00484257X (SPR)s00393-019-0680-1-e DE-627 ger DE-627 rakwb eng Albrecht, K. verfasserin aut Long-term trends in rheumatology care 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background Since 1993, data on the care and quality of life of patients with inflammatory rheumatic diseases have been collected in the German National Database (NDB) of the regional collaborative rheumatology centers. Objective In this review long-term trends on treatment, disease activity and gainful employment of the most common inflammatory rheumatic diseases are presented and the most important analyses from 25 years of the NDB are summarized. Methods Between 15 and 17 rheumatological institutions take part in the NDB and once a year collect data from a total of more than 10,000 patients. The rheumatologists document the disease status and care, the patients report on their state of health and the effects of the disease. Results The biologics era at the beginning of the twenty-first century has led to changes in the therapeutic spectrum of most inflammatory rheumatic diseases, especially in rheumatoid arthritis and ankylosing spondylitis. Some basic therapies formerly used are hardly used anymore and glucocorticoids are used less frequently. Methotrexate has remained the standard therapy for rheumatoid arthritis over the years. Nowadays, nearly 30% of patients with rheumatoid arthritis receive treatment with biologics. Disease activity, functional and social restrictions have decreased across all diseases. Conclusion The improved health status of many patients with rheumatic diseases confirms the high level of care provided by the rheumatism centers involved in the NDB. The increasing specification of measuring instruments and the standardization of documentation systems are major challenges that the NDB will have to face in the coming years if it is to remain in the digital age. Inflammatory rheumatic diseases (dpeaa)DE-He213 Treatment (dpeaa)DE-He213 Disease burden (dpeaa)DE-He213 Level of care (dpeaa)DE-He213 Quality of life (dpeaa)DE-He213 Callhoff, J. verfasserin aut Zink, A. verfasserin aut Enthalten in Zeitschrift für Rheumatologie Steinkopff-Verlag, 1998 78(2019), Suppl 2 vom: 12. Aug., Seite 65-72 (DE-627)SPR004818482 nnns volume:78 year:2019 number:Suppl 2 day:12 month:08 pages:65-72 https://dx.doi.org/10.1007/s00393-019-0680-1 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 78 2019 Suppl 2 12 08 65-72 |
| spelling |
10.1007/s00393-019-0680-1 doi (DE-627)SPR00484257X (SPR)s00393-019-0680-1-e DE-627 ger DE-627 rakwb eng Albrecht, K. verfasserin aut Long-term trends in rheumatology care 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background Since 1993, data on the care and quality of life of patients with inflammatory rheumatic diseases have been collected in the German National Database (NDB) of the regional collaborative rheumatology centers. Objective In this review long-term trends on treatment, disease activity and gainful employment of the most common inflammatory rheumatic diseases are presented and the most important analyses from 25 years of the NDB are summarized. Methods Between 15 and 17 rheumatological institutions take part in the NDB and once a year collect data from a total of more than 10,000 patients. The rheumatologists document the disease status and care, the patients report on their state of health and the effects of the disease. Results The biologics era at the beginning of the twenty-first century has led to changes in the therapeutic spectrum of most inflammatory rheumatic diseases, especially in rheumatoid arthritis and ankylosing spondylitis. Some basic therapies formerly used are hardly used anymore and glucocorticoids are used less frequently. Methotrexate has remained the standard therapy for rheumatoid arthritis over the years. Nowadays, nearly 30% of patients with rheumatoid arthritis receive treatment with biologics. Disease activity, functional and social restrictions have decreased across all diseases. Conclusion The improved health status of many patients with rheumatic diseases confirms the high level of care provided by the rheumatism centers involved in the NDB. The increasing specification of measuring instruments and the standardization of documentation systems are major challenges that the NDB will have to face in the coming years if it is to remain in the digital age. Inflammatory rheumatic diseases (dpeaa)DE-He213 Treatment (dpeaa)DE-He213 Disease burden (dpeaa)DE-He213 Level of care (dpeaa)DE-He213 Quality of life (dpeaa)DE-He213 Callhoff, J. verfasserin aut Zink, A. verfasserin aut Enthalten in Zeitschrift für Rheumatologie Steinkopff-Verlag, 1998 78(2019), Suppl 2 vom: 12. Aug., Seite 65-72 (DE-627)SPR004818482 nnns volume:78 year:2019 number:Suppl 2 day:12 month:08 pages:65-72 https://dx.doi.org/10.1007/s00393-019-0680-1 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 78 2019 Suppl 2 12 08 65-72 |
| allfields_unstemmed |
10.1007/s00393-019-0680-1 doi (DE-627)SPR00484257X (SPR)s00393-019-0680-1-e DE-627 ger DE-627 rakwb eng Albrecht, K. verfasserin aut Long-term trends in rheumatology care 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background Since 1993, data on the care and quality of life of patients with inflammatory rheumatic diseases have been collected in the German National Database (NDB) of the regional collaborative rheumatology centers. Objective In this review long-term trends on treatment, disease activity and gainful employment of the most common inflammatory rheumatic diseases are presented and the most important analyses from 25 years of the NDB are summarized. Methods Between 15 and 17 rheumatological institutions take part in the NDB and once a year collect data from a total of more than 10,000 patients. The rheumatologists document the disease status and care, the patients report on their state of health and the effects of the disease. Results The biologics era at the beginning of the twenty-first century has led to changes in the therapeutic spectrum of most inflammatory rheumatic diseases, especially in rheumatoid arthritis and ankylosing spondylitis. Some basic therapies formerly used are hardly used anymore and glucocorticoids are used less frequently. Methotrexate has remained the standard therapy for rheumatoid arthritis over the years. Nowadays, nearly 30% of patients with rheumatoid arthritis receive treatment with biologics. Disease activity, functional and social restrictions have decreased across all diseases. Conclusion The improved health status of many patients with rheumatic diseases confirms the high level of care provided by the rheumatism centers involved in the NDB. The increasing specification of measuring instruments and the standardization of documentation systems are major challenges that the NDB will have to face in the coming years if it is to remain in the digital age. Inflammatory rheumatic diseases (dpeaa)DE-He213 Treatment (dpeaa)DE-He213 Disease burden (dpeaa)DE-He213 Level of care (dpeaa)DE-He213 Quality of life (dpeaa)DE-He213 Callhoff, J. verfasserin aut Zink, A. verfasserin aut Enthalten in Zeitschrift für Rheumatologie Steinkopff-Verlag, 1998 78(2019), Suppl 2 vom: 12. Aug., Seite 65-72 (DE-627)SPR004818482 nnns volume:78 year:2019 number:Suppl 2 day:12 month:08 pages:65-72 https://dx.doi.org/10.1007/s00393-019-0680-1 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 78 2019 Suppl 2 12 08 65-72 |
| allfieldsGer |
10.1007/s00393-019-0680-1 doi (DE-627)SPR00484257X (SPR)s00393-019-0680-1-e DE-627 ger DE-627 rakwb eng Albrecht, K. verfasserin aut Long-term trends in rheumatology care 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background Since 1993, data on the care and quality of life of patients with inflammatory rheumatic diseases have been collected in the German National Database (NDB) of the regional collaborative rheumatology centers. Objective In this review long-term trends on treatment, disease activity and gainful employment of the most common inflammatory rheumatic diseases are presented and the most important analyses from 25 years of the NDB are summarized. Methods Between 15 and 17 rheumatological institutions take part in the NDB and once a year collect data from a total of more than 10,000 patients. The rheumatologists document the disease status and care, the patients report on their state of health and the effects of the disease. Results The biologics era at the beginning of the twenty-first century has led to changes in the therapeutic spectrum of most inflammatory rheumatic diseases, especially in rheumatoid arthritis and ankylosing spondylitis. Some basic therapies formerly used are hardly used anymore and glucocorticoids are used less frequently. Methotrexate has remained the standard therapy for rheumatoid arthritis over the years. Nowadays, nearly 30% of patients with rheumatoid arthritis receive treatment with biologics. Disease activity, functional and social restrictions have decreased across all diseases. Conclusion The improved health status of many patients with rheumatic diseases confirms the high level of care provided by the rheumatism centers involved in the NDB. The increasing specification of measuring instruments and the standardization of documentation systems are major challenges that the NDB will have to face in the coming years if it is to remain in the digital age. Inflammatory rheumatic diseases (dpeaa)DE-He213 Treatment (dpeaa)DE-He213 Disease burden (dpeaa)DE-He213 Level of care (dpeaa)DE-He213 Quality of life (dpeaa)DE-He213 Callhoff, J. verfasserin aut Zink, A. verfasserin aut Enthalten in Zeitschrift für Rheumatologie Steinkopff-Verlag, 1998 78(2019), Suppl 2 vom: 12. Aug., Seite 65-72 (DE-627)SPR004818482 nnns volume:78 year:2019 number:Suppl 2 day:12 month:08 pages:65-72 https://dx.doi.org/10.1007/s00393-019-0680-1 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 78 2019 Suppl 2 12 08 65-72 |
| allfieldsSound |
10.1007/s00393-019-0680-1 doi (DE-627)SPR00484257X (SPR)s00393-019-0680-1-e DE-627 ger DE-627 rakwb eng Albrecht, K. verfasserin aut Long-term trends in rheumatology care 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background Since 1993, data on the care and quality of life of patients with inflammatory rheumatic diseases have been collected in the German National Database (NDB) of the regional collaborative rheumatology centers. Objective In this review long-term trends on treatment, disease activity and gainful employment of the most common inflammatory rheumatic diseases are presented and the most important analyses from 25 years of the NDB are summarized. Methods Between 15 and 17 rheumatological institutions take part in the NDB and once a year collect data from a total of more than 10,000 patients. The rheumatologists document the disease status and care, the patients report on their state of health and the effects of the disease. Results The biologics era at the beginning of the twenty-first century has led to changes in the therapeutic spectrum of most inflammatory rheumatic diseases, especially in rheumatoid arthritis and ankylosing spondylitis. Some basic therapies formerly used are hardly used anymore and glucocorticoids are used less frequently. Methotrexate has remained the standard therapy for rheumatoid arthritis over the years. Nowadays, nearly 30% of patients with rheumatoid arthritis receive treatment with biologics. Disease activity, functional and social restrictions have decreased across all diseases. Conclusion The improved health status of many patients with rheumatic diseases confirms the high level of care provided by the rheumatism centers involved in the NDB. The increasing specification of measuring instruments and the standardization of documentation systems are major challenges that the NDB will have to face in the coming years if it is to remain in the digital age. Inflammatory rheumatic diseases (dpeaa)DE-He213 Treatment (dpeaa)DE-He213 Disease burden (dpeaa)DE-He213 Level of care (dpeaa)DE-He213 Quality of life (dpeaa)DE-He213 Callhoff, J. verfasserin aut Zink, A. verfasserin aut Enthalten in Zeitschrift für Rheumatologie Steinkopff-Verlag, 1998 78(2019), Suppl 2 vom: 12. Aug., Seite 65-72 (DE-627)SPR004818482 nnns volume:78 year:2019 number:Suppl 2 day:12 month:08 pages:65-72 https://dx.doi.org/10.1007/s00393-019-0680-1 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 78 2019 Suppl 2 12 08 65-72 |
| language |
English |
| source |
Enthalten in Zeitschrift für Rheumatologie 78(2019), Suppl 2 vom: 12. Aug., Seite 65-72 volume:78 year:2019 number:Suppl 2 day:12 month:08 pages:65-72 |
| sourceStr |
Enthalten in Zeitschrift für Rheumatologie 78(2019), Suppl 2 vom: 12. Aug., Seite 65-72 volume:78 year:2019 number:Suppl 2 day:12 month:08 pages:65-72 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Inflammatory rheumatic diseases Treatment Disease burden Level of care Quality of life |
| isfreeaccess_bool |
true |
| container_title |
Zeitschrift für Rheumatologie |
| authorswithroles_txt_mv |
Albrecht, K. @@aut@@ Callhoff, J. @@aut@@ Zink, A. @@aut@@ |
| publishDateDaySort_date |
2019-08-12T00:00:00Z |
| hierarchy_top_id |
SPR004818482 |
| id |
SPR00484257X |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR00484257X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519174951.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201001s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s00393-019-0680-1</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR00484257X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s00393-019-0680-1-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Albrecht, K.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Long-term trends in rheumatology care</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background Since 1993, data on the care and quality of life of patients with inflammatory rheumatic diseases have been collected in the German National Database (NDB) of the regional collaborative rheumatology centers. Objective In this review long-term trends on treatment, disease activity and gainful employment of the most common inflammatory rheumatic diseases are presented and the most important analyses from 25 years of the NDB are summarized. Methods Between 15 and 17 rheumatological institutions take part in the NDB and once a year collect data from a total of more than 10,000 patients. The rheumatologists document the disease status and care, the patients report on their state of health and the effects of the disease. Results The biologics era at the beginning of the twenty-first century has led to changes in the therapeutic spectrum of most inflammatory rheumatic diseases, especially in rheumatoid arthritis and ankylosing spondylitis. Some basic therapies formerly used are hardly used anymore and glucocorticoids are used less frequently. Methotrexate has remained the standard therapy for rheumatoid arthritis over the years. Nowadays, nearly 30% of patients with rheumatoid arthritis receive treatment with biologics. Disease activity, functional and social restrictions have decreased across all diseases. Conclusion The improved health status of many patients with rheumatic diseases confirms the high level of care provided by the rheumatism centers involved in the NDB. The increasing specification of measuring instruments and the standardization of documentation systems are major challenges that the NDB will have to face in the coming years if it is to remain in the digital age.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Inflammatory rheumatic diseases</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Treatment</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Disease burden</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Level of care</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Quality of life</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Callhoff, J.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zink, A.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Zeitschrift für Rheumatologie</subfield><subfield code="d">Steinkopff-Verlag, 1998</subfield><subfield code="g">78(2019), Suppl 2 vom: 12. Aug., Seite 65-72</subfield><subfield code="w">(DE-627)SPR004818482</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:78</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:Suppl 2</subfield><subfield code="g">day:12</subfield><subfield code="g">month:08</subfield><subfield code="g">pages:65-72</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s00393-019-0680-1</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">78</subfield><subfield code="j">2019</subfield><subfield code="e">Suppl 2</subfield><subfield code="b">12</subfield><subfield code="c">08</subfield><subfield code="h">65-72</subfield></datafield></record></collection>
|
| author |
Albrecht, K. |
| spellingShingle |
Albrecht, K. misc Inflammatory rheumatic diseases misc Treatment misc Disease burden misc Level of care misc Quality of life Long-term trends in rheumatology care |
| authorStr |
Albrecht, K. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)SPR004818482 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut |
| collection |
springer |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
Long-term trends in rheumatology care Inflammatory rheumatic diseases (dpeaa)DE-He213 Treatment (dpeaa)DE-He213 Disease burden (dpeaa)DE-He213 Level of care (dpeaa)DE-He213 Quality of life (dpeaa)DE-He213 |
| topic |
misc Inflammatory rheumatic diseases misc Treatment misc Disease burden misc Level of care misc Quality of life |
| topic_unstemmed |
misc Inflammatory rheumatic diseases misc Treatment misc Disease burden misc Level of care misc Quality of life |
| topic_browse |
misc Inflammatory rheumatic diseases misc Treatment misc Disease burden misc Level of care misc Quality of life |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Zeitschrift für Rheumatologie |
| hierarchy_parent_id |
SPR004818482 |
| hierarchy_top_title |
Zeitschrift für Rheumatologie |
| isfreeaccess_txt |
true |
| familylinks_str_mv |
(DE-627)SPR004818482 |
| title |
Long-term trends in rheumatology care |
| ctrlnum |
(DE-627)SPR00484257X (SPR)s00393-019-0680-1-e |
| title_full |
Long-term trends in rheumatology care |
| author_sort |
Albrecht, K. |
| journal |
Zeitschrift für Rheumatologie |
| journalStr |
Zeitschrift für Rheumatologie |
| lang_code |
eng |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2019 |
| contenttype_str_mv |
txt |
| container_start_page |
65 |
| author_browse |
Albrecht, K. Callhoff, J. Zink, A. |
| container_volume |
78 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Albrecht, K. |
| doi_str_mv |
10.1007/s00393-019-0680-1 |
| author2-role |
verfasserin |
| title_sort |
long-term trends in rheumatology care |
| title_auth |
Long-term trends in rheumatology care |
| abstract |
Background Since 1993, data on the care and quality of life of patients with inflammatory rheumatic diseases have been collected in the German National Database (NDB) of the regional collaborative rheumatology centers. Objective In this review long-term trends on treatment, disease activity and gainful employment of the most common inflammatory rheumatic diseases are presented and the most important analyses from 25 years of the NDB are summarized. Methods Between 15 and 17 rheumatological institutions take part in the NDB and once a year collect data from a total of more than 10,000 patients. The rheumatologists document the disease status and care, the patients report on their state of health and the effects of the disease. Results The biologics era at the beginning of the twenty-first century has led to changes in the therapeutic spectrum of most inflammatory rheumatic diseases, especially in rheumatoid arthritis and ankylosing spondylitis. Some basic therapies formerly used are hardly used anymore and glucocorticoids are used less frequently. Methotrexate has remained the standard therapy for rheumatoid arthritis over the years. Nowadays, nearly 30% of patients with rheumatoid arthritis receive treatment with biologics. Disease activity, functional and social restrictions have decreased across all diseases. Conclusion The improved health status of many patients with rheumatic diseases confirms the high level of care provided by the rheumatism centers involved in the NDB. The increasing specification of measuring instruments and the standardization of documentation systems are major challenges that the NDB will have to face in the coming years if it is to remain in the digital age. |
| abstractGer |
Background Since 1993, data on the care and quality of life of patients with inflammatory rheumatic diseases have been collected in the German National Database (NDB) of the regional collaborative rheumatology centers. Objective In this review long-term trends on treatment, disease activity and gainful employment of the most common inflammatory rheumatic diseases are presented and the most important analyses from 25 years of the NDB are summarized. Methods Between 15 and 17 rheumatological institutions take part in the NDB and once a year collect data from a total of more than 10,000 patients. The rheumatologists document the disease status and care, the patients report on their state of health and the effects of the disease. Results The biologics era at the beginning of the twenty-first century has led to changes in the therapeutic spectrum of most inflammatory rheumatic diseases, especially in rheumatoid arthritis and ankylosing spondylitis. Some basic therapies formerly used are hardly used anymore and glucocorticoids are used less frequently. Methotrexate has remained the standard therapy for rheumatoid arthritis over the years. Nowadays, nearly 30% of patients with rheumatoid arthritis receive treatment with biologics. Disease activity, functional and social restrictions have decreased across all diseases. Conclusion The improved health status of many patients with rheumatic diseases confirms the high level of care provided by the rheumatism centers involved in the NDB. The increasing specification of measuring instruments and the standardization of documentation systems are major challenges that the NDB will have to face in the coming years if it is to remain in the digital age. |
| abstract_unstemmed |
Background Since 1993, data on the care and quality of life of patients with inflammatory rheumatic diseases have been collected in the German National Database (NDB) of the regional collaborative rheumatology centers. Objective In this review long-term trends on treatment, disease activity and gainful employment of the most common inflammatory rheumatic diseases are presented and the most important analyses from 25 years of the NDB are summarized. Methods Between 15 and 17 rheumatological institutions take part in the NDB and once a year collect data from a total of more than 10,000 patients. The rheumatologists document the disease status and care, the patients report on their state of health and the effects of the disease. Results The biologics era at the beginning of the twenty-first century has led to changes in the therapeutic spectrum of most inflammatory rheumatic diseases, especially in rheumatoid arthritis and ankylosing spondylitis. Some basic therapies formerly used are hardly used anymore and glucocorticoids are used less frequently. Methotrexate has remained the standard therapy for rheumatoid arthritis over the years. Nowadays, nearly 30% of patients with rheumatoid arthritis receive treatment with biologics. Disease activity, functional and social restrictions have decreased across all diseases. Conclusion The improved health status of many patients with rheumatic diseases confirms the high level of care provided by the rheumatism centers involved in the NDB. The increasing specification of measuring instruments and the standardization of documentation systems are major challenges that the NDB will have to face in the coming years if it is to remain in the digital age. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA |
| container_issue |
Suppl 2 |
| title_short |
Long-term trends in rheumatology care |
| url |
https://dx.doi.org/10.1007/s00393-019-0680-1 |
| remote_bool |
true |
| author2 |
Callhoff, J. Zink, A. |
| author2Str |
Callhoff, J. Zink, A. |
| ppnlink |
SPR004818482 |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| doi_str |
10.1007/s00393-019-0680-1 |
| up_date |
2024-07-04T02:45:59.377Z |
| _version_ |
1803614850258042880 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR00484257X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519174951.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201001s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s00393-019-0680-1</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR00484257X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s00393-019-0680-1-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Albrecht, K.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Long-term trends in rheumatology care</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background Since 1993, data on the care and quality of life of patients with inflammatory rheumatic diseases have been collected in the German National Database (NDB) of the regional collaborative rheumatology centers. Objective In this review long-term trends on treatment, disease activity and gainful employment of the most common inflammatory rheumatic diseases are presented and the most important analyses from 25 years of the NDB are summarized. Methods Between 15 and 17 rheumatological institutions take part in the NDB and once a year collect data from a total of more than 10,000 patients. The rheumatologists document the disease status and care, the patients report on their state of health and the effects of the disease. Results The biologics era at the beginning of the twenty-first century has led to changes in the therapeutic spectrum of most inflammatory rheumatic diseases, especially in rheumatoid arthritis and ankylosing spondylitis. Some basic therapies formerly used are hardly used anymore and glucocorticoids are used less frequently. Methotrexate has remained the standard therapy for rheumatoid arthritis over the years. Nowadays, nearly 30% of patients with rheumatoid arthritis receive treatment with biologics. Disease activity, functional and social restrictions have decreased across all diseases. Conclusion The improved health status of many patients with rheumatic diseases confirms the high level of care provided by the rheumatism centers involved in the NDB. The increasing specification of measuring instruments and the standardization of documentation systems are major challenges that the NDB will have to face in the coming years if it is to remain in the digital age.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Inflammatory rheumatic diseases</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Treatment</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Disease burden</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Level of care</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Quality of life</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Callhoff, J.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zink, A.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Zeitschrift für Rheumatologie</subfield><subfield code="d">Steinkopff-Verlag, 1998</subfield><subfield code="g">78(2019), Suppl 2 vom: 12. Aug., Seite 65-72</subfield><subfield code="w">(DE-627)SPR004818482</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:78</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:Suppl 2</subfield><subfield code="g">day:12</subfield><subfield code="g">month:08</subfield><subfield code="g">pages:65-72</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s00393-019-0680-1</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">78</subfield><subfield code="j">2019</subfield><subfield code="e">Suppl 2</subfield><subfield code="b">12</subfield><subfield code="c">08</subfield><subfield code="h">65-72</subfield></datafield></record></collection>
|
| score |
7.399419 |